SG

Sudheera Guduru

Active Director Director DIN 10222108
DIN 10222108 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Sudheera Guduru

Data last updated:

Sudheera Guduru is a Director at Aaplans Pharma Private Limited (since 2023). The company operates in Paper. Aaplans Pharma Private Limited reported revenue of ₹20.04 Cr (FY 2025).

DIN 10222108
Primary Designation Director
Industry Paper
First Appointment 03 Jul 2023
Oldest Company Age 3 yrs
Largest company Aaplans Pharma Private Limited · ₹20.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aaplans Pharma Private Limited U21001TS2023PTC174530
Director03 Jul 20232023₹20.04 Cr (FY 2025)Active

Board colleagues of Sudheera Guduru

Directorship timeline

Open interactive timeline →
Aaplans Pharma Private Limited
Premium access

Shareholding and investment profile for Sudheera Guduru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudheera Guduru

Sudheera Guduru currently holds 1 directorship: Aaplans Pharma Private Limited (Director, since 03 Jul 2023, revenue ₹20.04 Cr (FY 2025)).

Sudheera Guduru was first appointed on 03 Jul 2023 as Director at Aaplans Pharma Private Limited.

The current boards of Sudheera Guduru's companies include Raja Gopal Reddy Guduru (Aaplans Pharma Private Limited), Siva Pratheek Guduru (Aaplans Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available